241 related articles for article (PubMed ID: 5695072)
21. Effect of penicillamine on failure of renal acidification in Wilson's disease.
Walshe JM
Lancet; 1968 Apr; 1(7546):775-8. PubMed ID: 4171128
[No Abstract] [Full Text] [Related]
22. [Penicillamine treatment of Wilson's disease].
Falkmer S; Samuelson G; Sjölin S
Lakartidningen; 1969 May; 66(20):2097-105. PubMed ID: 5795695
[No Abstract] [Full Text] [Related]
23. [Laboratory changes and complications during long-term therapy of Wilson's disease using D-penicillamine].
Hauftová D; Slavícek J; Hartl J; Seidlová V; Komenda S
Vnitr Lek; 1970 Apr; 16(4):344-53. PubMed ID: 5443326
[No Abstract] [Full Text] [Related]
24. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice.
Hoogenraad TU
Brain Dev; 2006 Apr; 28(3):141-6. PubMed ID: 16466879
[TBL] [Abstract][Full Text] [Related]
25. [Urine copper determination in Wilson's disease during therapy].
Schnack H
Wien Z Inn Med; 1967; 48(12):469-76. PubMed ID: 5620588
[No Abstract] [Full Text] [Related]
26. [Presymptomatic and hepatic forms of Wilson's disease in childhood. Long-term therapy with D-penicillamine].
Kittoe K; Colombo JP
Praxis; 1968 Dec; 57(49):1723-9. PubMed ID: 5756864
[No Abstract] [Full Text] [Related]
27. [2 cases of verruciform perforating elastoma after prolonged administration of D-penicillamine in Wilson's disease].
Sfar Z; Lakhoua H; Hafsia M; Amor RB; Mahfoudh H; Hamza B; Abdallah CB
Tunis Med; 1977; 55(3):167-8. PubMed ID: 919044
[No Abstract] [Full Text] [Related]
28. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.
Farinati F; Cardin R; D'inca R; Naccarato R; Sturniolo GC
J Lab Clin Med; 2003 Jun; 141(6):372-7. PubMed ID: 12819634
[TBL] [Abstract][Full Text] [Related]
29. Hemolytic anemia of Wilson's disease.
Iser JH; Stevens BJ; Stening GF; Hurley TH; Smallwood RA
Gastroenterology; 1974 Aug; 67(2):290-3. PubMed ID: 4847708
[No Abstract] [Full Text] [Related]
30. Effect of D,L-penicillamine on the urinary excretion of copper and calcium in hepatolenticular degeneration (Wilson's disease).
LITIN RB; GOLDSTEIN NP; RANDALL RV; POWER MH; DIESSNER GR
Neurology; 1960 Feb; 10():123-6. PubMed ID: 14417516
[No Abstract] [Full Text] [Related]
31. [Favorable results with an association of L-dopa and amantadine added to penicillamine in the treatment of Wilson's disease].
Berio A; Vento R; Di Stefano A
Minerva Pediatr; 1973 May; 25(18):807-13. PubMed ID: 4732090
[No Abstract] [Full Text] [Related]
32. [New views on the etiology, diagnosis and therapy of Wilson's disease].
Linke A
Z Arztl Fortbild (Jena); 1967 Dec; 61(24):1273-6. PubMed ID: 4873428
[No Abstract] [Full Text] [Related]
33. Wilson's disease: assessment of D-penicillamine treatment.
Van Caillie-Bertrand M; Degenhart HJ; Luijendijk I; Bouquet J; Sinaasappel M
Arch Dis Child; 1985 Jul; 60(7):652-5. PubMed ID: 4026361
[TBL] [Abstract][Full Text] [Related]
34. Relationship between striatal glucose consumption and copper excretion in patients with Wilson's disease treated with D-penicillamine.
Hefter H; Kuwert T; Herzog H; Arendt G; Stremmel W; Feinendegen LE
J Neurol; 1993 Nov; 241(1):49-53. PubMed ID: 8138822
[TBL] [Abstract][Full Text] [Related]
35. [Wilson's disease (hepatocerebral degeneration)].
Sternlieb I
Internist (Berl); 1976 Jul; 17(7):342-7. PubMed ID: 780309
[No Abstract] [Full Text] [Related]
36. Membranoproliferative glomerulonephritis in a patient with Wilson's disease.
Ozçakar ZB; Ekim M; Ensari A; Kuloglu Z; Yüksel S; Acar B; Kirsaçlioglu C; Kansu A; Yalçinkaya F; Girgin N
J Nephrol; 2006; 19(6):831-3. PubMed ID: 17173260
[TBL] [Abstract][Full Text] [Related]
37. Screening asymptomatic family members for Wilson's disease.
Lindahl JA; Sharp HL
Minn Med; 1982 Aug; 65(8):473-5. PubMed ID: 6752690
[No Abstract] [Full Text] [Related]
38. Diagnosis and management of Wilson's disease: results of a single center experience.
Medici V; Trevisan CP; D'Incà R; Barollo M; Zancan L; Fagiuoli S; Martines D; Irato P; Sturniolo GC
J Clin Gastroenterol; 2006; 40(10):936-41. PubMed ID: 17063115
[TBL] [Abstract][Full Text] [Related]
39. [Hepatolenticular degeneration. Wilson's disease].
Hansen HJ; Andersen OS
Ugeskr Laeger; 1969 Jul; 131(31):1301-5. PubMed ID: 4898805
[No Abstract] [Full Text] [Related]
40. [The onset of psychiatric disorders and Wilson's disease].
Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
